ConductScience.org, home

Paper41018706

Developing a Simple Scoring System on CT Findings for Predicting Treatment Failure in Mycobacterium avium Complex Pulmonary Disease: The BCD (Bronchiectasis and Cavity Distribution) Score.

Hayashi M and 5 others. Open Forum Infect Dis, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Developing a Simple Scoring System on CT Findings for Predicting Treatment Failure in Mycobacterium avium Complex Pulmonary Disease: The BCD (Bronchiectasis and Cavity Distribution) Score. Papers, record 41018706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41018706

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Developing a Simple Scoring System on CT Findings for Predicting Treatment Failure in Mycobacterium avium Complex Pulmonary Disease: The BCD (Bronchiectasis and Cavity Distribution) Score.
PubMed
Journal
Open Forum Infect Dis
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-10-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hayashi MMakotohttps://orcid.org/0000-0003-0799-8531
2Takishima HHiroyasu
3Cho HHidekazu
4Yamaguchi FFumihirohttps://orcid.org/0000-0003-1611-6991
5Yokoe TTakuya
6Matsukura SSatoshi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137423256Microbiological Cure at Treatment Completion Is Associated With Longer Survival in Patients With Mycobacterium avium Complex Pulmonary Disease.Chest2023https://conductscience.org/library/papers/37423256PubMed
231611366Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/31611366PubMed
333796599Clinical Implications of Size of Cavities in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Single-Center Cohort Study.Open Forum Infect Dis2021https://conductscience.org/library/papers/33796599PubMed
432141923Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals.Crit Care Med2020https://conductscience.org/library/papers/32141923PubMed
537022189Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use.Microbiol Spectr2023https://conductscience.org/library/papers/37022189PubMed
634793759Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality.Chest2022https://conductscience.org/library/papers/34793759PubMed
728954780Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype.Eur Respir J2017https://conductscience.org/library/papers/28954780PubMed
831915013Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort study.Respir Res2020https://conductscience.org/library/papers/31915013PubMed
939582505
The Long and Winding Road: Three-year Mortality Following Prescription of Multidrug Antibiotic Treatment for Mycobacterium avium complex Pulmonary Disease in United States Medicare Beneficiaries With Bronchiectasis.
Open Forum Infect Dis2024https://conductscience.org/library/papers/39582505PubMed
1024059365Serial CT findings of nodular bronchiectatic Mycobacterium avium complex pulmonary disease with antibiotic treatment.AJR Am J Roentgenol2013https://conductscience.org/library/papers/24059365PubMed
1135505476M. avium complex pulmonary disease: does the diagnostic method affect severity and progression?Int J Tuberc Lung Dis2022https://conductscience.org/library/papers/35505476PubMed
1229567726Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.Eur Respir J2018https://conductscience.org/library/papers/29567726PubMed
1334046491Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics.ERJ Open Res2021https://conductscience.org/library/papers/34046491PubMed
1435748569Mortality association of nontuberculous mycobacterial infection requiring treatment in Taiwan: a population-based study.Ther Adv Respir Dis2022https://conductscience.org/library/papers/35748569PubMed
1528541556Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic Progression.Clin Infect Dis2017https://conductscience.org/library/papers/28541556PubMed
1636244600Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.Int J Infect Dis2022https://conductscience.org/library/papers/36244600PubMed
1732721164BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease.Am J Respir Crit Care Med2021https://conductscience.org/library/papers/32721164PubMed
1832442113Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.Respir Med2020https://conductscience.org/library/papers/32442113PubMed
1940153596Intermittent versus Daily Therapy for Noncavitary Mycobacterium avium Complex Pulmonary Disease: An Open-Label Randomized Trial.Ann Am Thorac Soc2025https://conductscience.org/library/papers/40153596PubMed
2024298907Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.Ann Am Thorac Soc2014https://conductscience.org/library/papers/24298907PubMed

See all 43 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42984813
Species distribution and antimicrobial susceptibility profiles of nontuberculous mycobacteria, with an exploratory 12-month completer outcome analysis: a single-center retrospective study from Shandong Province, China.
Front Microbiol2026https://conductscience.org/library/papers/42984813PubMed
41638757Clinical characteristics of pulmonary non-tuberculous mycobacterial disease with CFTR variants in the Japanese population.BMJ Open Respir Res2026https://conductscience.org/library/papers/41638757PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41018706

GET https://conductscience.org/api/papers/v1/41018706/references?page=2